Cargando…
Targeting metastatic colorectal cancer – present and emerging treatment options
Metastatic colorectal cancer is a significant cause of morbidity and mortality in the US and around the world. While several novel cytotoxic and biologic therapies have been developed and proven efficacious in the past two decades, their optimal use in terms of patient selection, drug combinations,...
Autores principales: | Ciombor, Kristen K, Berlin, Jordan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100688/ https://www.ncbi.nlm.nih.gov/pubmed/25045279 http://dx.doi.org/10.2147/PGPM.S47582 |
Ejemplares similares
-
Selecting treatment options in refractory metastatic colorectal cancer
por: Byrne, Margaret, et al.
Publicado: (2019) -
Apatinib as an optional treatment in metastatic colorectal cancer
por: Li, Aiyi, et al.
Publicado: (2019) -
Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept
por: Dietvorst, Maria H. P., et al.
Publicado: (2013) -
Up-and-Coming Experimental Drug Options for Metastatic Colorectal Cancer
por: Cimino, Sarah K, et al.
Publicado: (2020) -
Emerging Treatment Options for the Treatment of Metastatic Urothelial Cancer: Therapeutic Potential of Enfortumab Vedotin
por: Jain, Rohit K, et al.
Publicado: (2020)